In the remote past, declines in CFTR and ARSB may have provided a selective advantage to humans against malaria, since malarial-infected red blood cells bind less well to the endothelium when chondroitin 4-sulfate is more sulfated [9,10,11], implying a survival benefit against malaria from ARSB deficiency. Here, ARSB is linked to malaria.